EIF5A and lung adenocarcinoma: Elevated expression of the elongation factor eIF5A is also associated with the development of several types of cancer4,5, including lung metastasis6 and eIF5A is a prognostic marker for poor lung adenocarcinoma patient outcome, however a lack of understanding of its role in mRNA translation restricts therapeutic targeting strategies7–10.